Search Results 1481-1490 of 19471 for Hemoglobin

  1. A Study to Evaluate Estetrol to Treat Moderate-to-Severe Vasomotor Symptoms in Postmenopausal Women - Mayo Clinic

    ... hemoglobin above 7%; 9. Dyslipoproteinaemia (LDL >190 mg/dL and triglycerides >300 mg/dL); 10. Smoking: 1. Efficacy Study part: subjects smoking >5 ...

  2. A Study of DCC-2618 vs. Sunitinib in Advanced GIST Patients after Treatment with Imatinib - Mayo Clinic

    Hemoglobin ≥ 8 g/dL;; Platelet count ≥ 75,000/μ;; Total bilirubin ≤ 1.5 x the upper limit of normal (ULN);; Aspartate transaminase (AST) and alanine ...

  3. A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dL independent of transfusion within 7 days of first dose of study drug. 6. Adequate renal and hepatic function as indicated by: a ...

  4. A Study To Investigate The Efficacy, Safety, And Pharmacokinetics Of Oral Rilzabrutinib Compared With Placebo In Participants 18 Years Of Age And Older With Warm Autoimmune Hemolytic Anemia - Mayo Clinic

    * Participants who have previously failed to maintain a sustained response after treatment with CS (CS-resistance \[defined as failure to obtain hemoglobin ...

  5. Phase 2/3 Study Of Efficacy And Safety Of THRV-1268 In Long QT Syndrome Type 2 (LQTS 2) - Mayo Clinic

    Has clinically significant abnormality in serum chemistry values at Screening for hemoglobin, potassium, magnesium, or calcium levels as determined by the ...

  6. Stories for Change: Digital Storytelling for Diabetes Self-Management among Hispanic Adults - Mayo Clinic

    Most recent hemoglobin A1c≥8%, and; Intention to continue to receive medical care at the recruitment clinic for the next six months. Participating Mayo ...

  7. Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer - Mayo Clinic

    Hemoglobin >= 9 g/dL; Thyroid stimulating hormone (TSH) < lower limit of normal (LLN) (patients not able to tolerate TSH suppression can be granted an ...

  8. Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dL;; Total bilirubin ≤ 1.5 x the upper limit of the normal range (ULN);; Aspartate aminotransferase (AST) ≤ 3 x ULN;; Alanine ...

  9. A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) - Mayo Clinic

    Hemoglobin ≥ 90 g/L (9.0 g/dL). Patients may be transfused to meet this criterion. AST, ALT, and ALP ≤ 2.5 x upper limit of normal (ULN); Serum bilirubin ...

  10. Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer - Mayo Clinic

    Hemoglobin (Hgb) within normal limits for institution/lab; Platelet count ≥ 100,000/ul; White blood cell count (WBC) ≥ 3,000/ul; Alanine aminotransferase ...